GILD vs TW · P/E 18, rev $29.44B vs P/E 25, rev $1.73B
Gilead Sciences Inc (GILD) versus Tradeweb Markets Inc (TW) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Tradeweb Markets Inc (TW) is a capital markets company listed on NASDAQ.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported TW revenue for 2024-12-31 was $1.73B. Net income was $570.0M. Revenue was up 29.0% from 2023-12-31 to 2024-12-31. TW currently screens at market cap $21.86B and trailing P/E 24.8.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. TW currently screens at market cap $21.86B and trailing P/E 24.8.
Not investment advice. Open the GILD and TW stock pages for the full models.
Not investment advice.